{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:47:55Z","timestamp":1770482875265,"version":"3.49.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T00:00:00Z","timestamp":1403136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002942","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T20:40:58Z","timestamp":1403210458000},"page":"e2942","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Madurella mycetomatis Is Highly Susceptible to Ravuconazole"],"prefix":"10.1371","volume":"8","author":[{"given":"Sarah Abdalla","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Kloezen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Duncanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed E.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Sybren","family":"de Hoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed H.","family":"Fahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy W. J.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/edm.13.31","article-title":"Managing mycetoma: guidelines for best practice","volume":"8","author":"AH Fahal","year":"2013","journal-title":"Expert Rev Dermatol"},{"key":"ref2","first-page":"514","article-title":"Review: Mycetoma","volume":"04","author":"AH Fahal","year":"2011","journal-title":"Khartoum Med J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1473-3099(04)01131-4","article-title":"Mycetoma caused by <italic>Madurella mycetomatis<\/italic>: a neglected infectious burden","volume":"4","author":"AO Ahmed","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1128\/AAC.01170-12","article-title":"<italic>In vitro<\/italic> antifungal activity of isavuconazole against <italic>Madurella mycetomatis<\/italic>","volume":"56","author":"W Kloezen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.01045-10","article-title":"<italic>In vitro<\/italic> susceptibility of <italic>Madurella mycetomatis<\/italic> to posaconazole and terbinafine. Antimicrob","volume":"55","author":"A van Belkum","year":"2011","journal-title":"Agents Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.49.4.1364-1368.2005","article-title":"Testing of the <italic>in vitro<\/italic> susceptibilities of <italic>Madurella mycetomatis<\/italic> to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method","volume":"49","author":"WW van de Sande","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.trstmh.2012.07.003","article-title":"Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan","volume":"106","author":"HA Zein","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref8","unstructured":"European Medicines Agency (2013). European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. Benefit of oral ketoconazole does not outweigh risk of liver injury in fungal infections. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Ketoconazole-containing_medicines\/WC500146616.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Ketoconazole-containing_medicines\/WC500146616.pdf<\/ext-link> Accessed 23 May 2014."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/jm9707277","article-title":"New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones","volume":"41","author":"J Bartroli","year":"1998","journal-title":"J Med Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/AAC.42.2.313","article-title":"<italic>In vitro<\/italic> activity of a new oral triazole, BMS-207147 (ER-30346)","volume":"42","author":"JC Fung-Tomc","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1128\/AAC.43.9.2236","article-title":"<italic>In vitro<\/italic> activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America","volume":"43","author":"DJ Diekema","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0924-8579(02)00273-X","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> activities of ravuconazole on <italic>Trypanosoma cruzi<\/italic>, the causative agent of Chagas disease","volume":"21","author":"JA Urbina","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpddr.2011.12.002","article-title":"Recent Developments in Sterol 14-demethylase Inhibitors for Chagas Disease","volume":"2","author":"FS Buckner","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e2229","DOI":"10.1371\/journal.pntd.0002229","article-title":"Phylogenetic findings suggest possible new habitat and routes of infection of human eumycetoma","volume":"7(5)","author":"GS de Hoog","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.48.7.2742-2746.2004","article-title":"<italic>In vitro<\/italic> susceptibilities of <italic>Madurella mycetomatis<\/italic> to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay","volume":"48","author":"AO Ahmed","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1128\/AAC.49.12.5136-5138.2005","article-title":"<italic>In vitro<\/italic> activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi","volume":"49","author":"M Cuenca-Estrella","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1469-0691.2003.00755.x","article-title":"<italic>In vitro<\/italic> activity of ravuconazole against Zygomycetes, <italic>Scedosporium<\/italic> and <italic>Fusarium<\/italic> isolates","volume":"9","author":"B Minassian","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.47.10.3161-3164.2003","article-title":"<italic>In vitro<\/italic> activities of new antifungal agents against <italic>Chaetomium<\/italic> spp. and inoculum standardization","volume":"47","author":"C Serena","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/AAC.44.10.2883-2886.2000","article-title":"<italic>In vitro<\/italic> activities of ravuconazole (BMS-207147) against 541 clinical isolates of <italic>Cryptococcus neoformans<\/italic>","volume":"44","author":"T Yamazumi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/AAC.46.6.1723-1727.2002","article-title":"<italic>In vitro<\/italic> activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of <italic>Candida<\/italic> spp","volume":"46","author":"MA Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.47.4.1193-1199.2003","article-title":"<italic>In vivo<\/italic> pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model","volume":"47","author":"D Andes","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1128\/AAC.45.12.3433-3436.2001","article-title":"Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice","volume":"45","author":"KV Clemons","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/AAC.40.10.2243","article-title":"Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis","volume":"40","author":"K Hata","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","first-page":"i19","article-title":"New and emerging treatments for fungal infections. J Antimicrob Chemother","volume":"61","author":"AC Pasqualotto","year":"2008"},{"key":"ref25","unstructured":"E1224 Fifth Edition Global Investigator Brochure March 29, 2013."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dki287","article-title":"Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits","volume":"56","author":"AH Groll","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000048580","article-title":"Penetration of ravuconazole, a new triazole antifungal, into rat tissues","volume":"48","author":"H Mikamo","year":"2002","journal-title":"Chemotherapy"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.46.3.922-924.2002","article-title":"Efficacy of ravuconazole in treatment of systemic murine histoplasmosis","volume":"46","author":"KV1 Clemons","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/49.2.353","article-title":"Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis","volume":"49","author":"WR1 Kirkpatrick","year":"2002","journal-title":"J Antimicrob Chemother"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T05:22:04Z","timestamp":1597987324000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002942"}},"subtitle":[],"editor":[{"given":"Bodo","family":"Wanke","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002942","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}